Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
222 East 41st Street
12th Floor
New York, NY 10017- Is this information wrong?
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2004 - 2007
Lahey ClinicResidency, Urology, 2000 - 2004- Lahey ClinicResidency, Surgery, 1998 - 2000
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1998
Certifications & Licensure
NY State Medical License 2004 - 2025
NJ State Medical License 2023 - 2025
MA State Medical License 2000 - 2004
ME State Medical License Active through 2003
PA State Medical License 2000 - 2002- American Board of Urology Urology
- Society of Urologic OncologyFellow
Awards, Honors, & Recognition
- America’s Top Doctors for Cancer Castle Connolly, 2018-2021
- Top Doctors New York Magazine, 2016, 2018-2021
- Regional Top Doctor Castle Connolly, 2014-2017
- Join now to see all
Clinical Trials
- A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer Start of enrollment: 2022 Mar 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Corrigendum to "RPN (Radius, Position of tumour, iNvasion of renal sinus) Classification and Nephrometry Scoring System: An Internationally Developed Clinical Classifi...Dinesh K Agarwal, Clancy Mulholland, Digsu N Koye, Niranjan Sathianathen, Henry Yao, Philip Dundee, Daniel Moon, Marc Furrer, Christina Giudice, Wayland Wang, Julie A ...> ;European Urology Open Science. 2024 May 1
- Interaction of patient age and high-grade prostate cancer on targeted biopsies of MRI suspicious lesions.Richard Huang, Jamie S Pak, William C Huang, Herbert Lepor, James S Wysock, Samir S Taneja> ;BJU International. 2024 Mar 27
- 1 citationsTreatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection ...Sandip M Prasad, William C Huang, Neal D Shore, Brian Hu, Marc Bjurlin, Gordon Brown, Pencho Genov, Dimitar Shishkov, Alexandre Khuskivadze, Tosho Ganev, Dobri Marchev...> ;The Journal of Urology. 2023 Oct 1
- Join now to see all
Authored Content
- Is Imperative Partial Nephrectomy Feasible for Kidney Cancer with Venous Thrombus Involvement? Outcomes of 42 Cases and Matched Pair Analysis with a Large Radical Nephrectomy CohortMay 2018
- Is Imperative Partial Nephrectomy Feasible for Kidney Cancer with Venous Thrombus Involvement? Outcomes of 42 Cases and Matched Pair Analysis with a Large Radical Nephrectomy CohortMay 2018
- Is Imperative Partial Nephrectomy Feasible for Kidney Cancer with Venous Thrombus Involvement? Outcomes of 42 Cases and Matched Pair Analysis with a Large Radical Nephrectomy CohortMay 2018
Press Mentions
UroGen Announces New Data from the OPTIMA II Study That Show Median Durability of Response of 24.4 Months for UGN-102, an Investigational Non-Surgical Chemoablative Treatment for Low-Grade, Intermediate-Risk Non-Muscle Invasive Bladder CancerDecember 2nd, 2022
KCCure Represents Patients at AUA 2018May 27th, 2018
Robotic Approaches Advancing Surgical Scope in Muscle-Invasive Bladder CancerFebruary 7th, 2018- Join now to see all
Professional Memberships
- Member
- Society of Urologic OncologyFellow
Hospital Affiliations
VA NY Harbor Healthcare System, Manhattan CampusBrooklyn, New York
NYC Health + Hospitals / BellevueNew York, New York
NYU Langone HospitalsNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
